Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • IBseq
    Member
    • Jul 2012
    • 56

    #1

    how to identify differentially expressed genes from cuffdiff output?

    Hi guys,
    have a question about the cuffdiff output "differential expression testing".

    For most of you might sound "naive" but I'm new to this field and I
    have very little background in statistic.

    So, I have compared a control sample with 2 biological replicates
    using cuffdiff. I have now about 4000 genes which were tested.

    1. How do I extrapolate the genes which are up- or downregulated from the 4000?

    2. Is there a FPKM value above which a gene is up- or downregulated?

    3.I used excel and sorted the values from highest to smallest:
    assuming that control highest value is 200 and the correspondent
    treated values is 2, can I say that that gene is downregulated in the
    treated ssamples by a 100 fold chnage?

    4. Do I have to use at all the p_values given in the output to
    extrapolate the most up- or downregualted genes?

    I do not have yet cummerbund and I am not very good with R. And I 'm lost!

    Thanks,
    ib
  • DZhang
    Senior Member
    • Jun 2010
    • 177

    #2
    Hi IBseq,

    Here are a few practical suggestions hopefully to get you started:

    1) Decide whether you need transcript-level or gene-level quantitation. It depends on what kind of biological questions you are trying to address. (cuffdiff gives both, just in case you want to know.)
    2) Please consider both fold change and p-value in deciding which genes/transcripts as most significantly changed for follow-up studies.
    3) Always use independent experiments to verify the differentially expressed genes. Statistics has it own limitations, and so are the technologies.
    4) For one specific question, yes, you may say that gene has 100-fold change. But be aware of the small numbers. The count of 2 is not very reliable. If the control has none and your experimental group has 1, mathematically, it is infinitely increase but in reality you cannot really tell.

    Good luck learning R!

    Douglas

    Comment

    • jp.
      Senior Member
      • Jul 2013
      • 142

      #3
      May please someone guide me for pathway analysis after cuffdiff events?
      I have some sig diff but I dont know how to do pathway analysis. Are there some commnads or rules something , a bit in detail, if somebody know?
      thank you

      Comment

      • DonDolowy
        Member
        • Oct 2012
        • 56

        #4
        You can run GSEA to identify enriched gene sets in (here you submit a matrix containing expression values for all genes in between your two conditions).
        If you want to study only the DEGs, then you can go for GO analysis.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 10:13 AM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Working...